CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Fresenius SE & Co KGaA - FRE CFD

26.86
0.79%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.10
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022102 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022102%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000121 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000121%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Fresenius SE & Co KGaA ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 26.65
Open* 26.45
1-Year Change* 2.84%
Day's Range* 26.36 - 26.86
52 wk Range 23.29-31.22
Average Volume (10 days) 1.00M
Average Volume (3 months) 24.66M
Market Cap 14.73B
P/E Ratio 19.17
Shares Outstanding 563.24M
Revenue 27.26B
EPS 1.36
Dividend (Yield %) 3.51682
Beta 1.11
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 26.86 0.43 1.63% 26.43 26.89 26.28
Apr 18, 2024 26.65 0.15 0.57% 26.50 26.70 26.37
Apr 17, 2024 26.53 0.08 0.30% 26.45 26.86 26.45
Apr 16, 2024 26.62 1.25 4.93% 25.37 26.65 25.37
Apr 15, 2024 25.42 0.18 0.71% 25.24 25.60 25.24
Apr 12, 2024 25.39 -0.02 -0.08% 25.41 25.63 25.23
Apr 11, 2024 25.21 0.09 0.36% 25.12 25.57 24.81
Apr 10, 2024 25.21 -0.21 -0.83% 25.42 25.65 25.04
Apr 9, 2024 25.31 -0.17 -0.67% 25.48 25.60 25.02
Apr 8, 2024 25.71 0.75 3.00% 24.96 25.80 24.95
Apr 5, 2024 25.05 0.17 0.68% 24.88 25.32 24.88
Apr 4, 2024 25.07 0.60 2.45% 24.47 25.14 24.47
Apr 3, 2024 24.57 0.06 0.24% 24.51 24.61 24.31
Apr 2, 2024 24.61 -0.28 -1.12% 24.89 25.06 24.51
Mar 28, 2024 24.91 -0.11 -0.44% 25.02 25.34 24.86
Mar 27, 2024 24.89 0.22 0.89% 24.67 25.06 24.49
Mar 26, 2024 24.65 0.38 1.57% 24.27 24.66 24.27
Mar 25, 2024 24.48 -0.09 -0.37% 24.57 24.64 24.40
Mar 22, 2024 24.67 0.08 0.33% 24.59 24.80 24.59
Mar 21, 2024 24.64 -0.32 -1.28% 24.96 24.96 24.47

Fresenius SE & Co KGaA Events

Time (UTC) Country Event
Wednesday, May 8, 2024

Time (UTC)

06:30

Country

DE

Event

Q1 2024 Fresenius SE & Co KGaA Earnings Release
Q1 2024 Fresenius SE & Co KGaA Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

DE

Event

Q1 2024 Fresenius SE & Co KGaA Earnings Call
Q1 2024 Fresenius SE & Co KGaA Earnings Call

Forecast

-

Previous

-
Friday, May 17, 2024

Time (UTC)

10:59

Country

DE

Event

Fresenius SE & Co KGaA Annual Shareholders Meeting
Fresenius SE & Co KGaA Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, July 31, 2024

Time (UTC)

06:30

Country

DE

Event

Q2 2024 Fresenius SE & Co KGaA Earnings Release
Q2 2024 Fresenius SE & Co KGaA Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

DE

Event

Q2 2024 Fresenius SE & Co KGaA Earnings Call
Q2 2024 Fresenius SE & Co KGaA Earnings Call

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 40840 37520 36277 35409 33530
Revenue 40840 37520 36277 35409 33530
Cost of Revenue, Total 30115 27209 25961 25061 23696
Gross Profit 10725 10311 10316 10348 9834
Total Operating Expense 37519 33362 31892 30778 28279
Selling/General/Admin. Expenses, Total 6744 5453 5430 5406 4873
Research & Development 811 762 724 603 650
Depreciation / Amortization 31 22 20 17 16
Unusual Expense (Income) 25 21 -24 -4 -802
Other Operating Expenses, Total -207 -105 -219 -305 -154
Operating Income 3321 4158 4385 4631 5251
Interest Income (Expense), Net Non-Operating -507 -506 -659 -719 -587
Net Income Before Taxes 2814 3652 3726 3912 4664
Net Income After Taxes 2117 2819 2823 3029 3714
Minority Interest -745 -1001 -1116 -1146 -1687
Net Income Before Extra. Items 1372 1818 1707 1883 2027
Net Income 1372 1818 1707 1883 2027
Income Available to Common Excl. Extra. Items 1372 1818 1707 1883 2027
Income Available to Common Incl. Extra. Items 1372 1818 1707 1883 2027
Diluted Net Income 1372 1818 1707 1883 2027
Diluted Weighted Average Shares 561.264 558.156 557.744 557.417 557.305
Diluted EPS Excluding Extraordinary Items 2.44448 3.25715 3.06054 3.37808 3.63715
Dividends per Share - Common Stock Primary Issue 0.92 0.92 0.88 0.84 0.8
Diluted Normalized EPS 3.13934 2.6265 3.34581 3.5531 2.65123
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 10359 10225 10643 10459 10018
Revenue 10359 10225 10643 10459 10018
Cost of Revenue, Total 8026 7714 7859 7754 7340
Gross Profit 2333 2511 2784 2705 2678
Total Operating Expense 9816 9438 9956 9572 9173
Selling/General/Admin. Expenses, Total 1589 1552 1820 1610 1631
Research & Development 190 188 242 200 195
Depreciation / Amortization 11 10 10 9 7
Operating Income 543 787 687 887 845
Interest Income (Expense), Net Non-Operating -184 -170 -132 -141 -116
Net Income Before Taxes 359 617 555 746 729
Net Income After Taxes 166 463 403 552 564
Minority Interest -86 -117 -148 -230 -181
Net Income Before Extra. Items 80 346 255 322 383
Net Income 80 346 255 322 383
Income Available to Common Excl. Extra. Items 80 346 255 321 383
Income Available to Common Incl. Extra. Items 80 346 255 321 383
Diluted Net Income 80 346 255 321 383
Diluted Weighted Average Shares 533.333 563.237 563.237 563.237 563.235
Diluted EPS Excluding Extraordinary Items 0.15 0.61431 0.45274 0.56992 0.68
Dividends per Share - Common Stock Primary Issue 0 0 0.92 0 0
Diluted Normalized EPS 0.88875 0.77232 1.4825 0.48292 0.51311
Unusual Expense (Income) 25
Other Operating Expenses, Total -1
Interest Expense (Income) - Net Operating -26
Total Adjustments to Net Income -1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 18279 17461 15772 15264 14790
Cash and Short Term Investments 2749 931 1716 1543 2586
Cash 1071 1047 1150
Cash & Equivalents 2749 931 645 496 1436
Short Term Investments
Total Receivables, Net 7165 9308 8695 8972 7766
Accounts Receivable - Trade, Net 7008 7532 7411 7880 6628
Total Inventory 4833 4218 3945 3633 3218
Prepaid Expenses 441 459 273 147
Other Current Assets, Total 3532 2563 957 843 1073
Total Assets 76400 71962 66646 67006 56703
Property/Plant/Equipment, Total - Net 18841 18583 17603 17266 10366
Property/Plant/Equipment, Total - Gross 32271 29156 27566 18881
Accumulated Depreciation, Total -13688 -11553 -10300 -8515
Goodwill, Net 31490 28943 26599 27737 25713
Intangibles, Net 4338 3831 3736 3869 3130
Long Term Investments
Note Receivable - Long Term 132 220 723
Other Long Term Assets, Total 3452 3144 2804 2650 1981
Total Current Liabilities 13658 15062 13216 13884 13275
Accounts Payable 2070 2039 1816 1905 1823
Accrued Expenses 1150 915 1056 3298
Notes Payable/Short Term Debt 856 2841 245 2475 0
Current Port. of LT Debt/Capital Leases 2180 1931 3425 3033 5094
Other Current Liabilities, Total 8552 7101 6815 5415 3060
Total Liabilities 55985 52964 49697 50228 41292
Total Long Term Debt 24727 22383 22243 21750 14040
Long Term Debt 18986 16625 16821 16104 13821
Capital Lease Obligations 5741 5758 5422 5646 219
Deferred Income Tax 1654 1515 1390 1418 1284
Minority Interest 11803 10290 9074 9802 9597
Other Liabilities, Total 4143 3714 3774 3374 3096
Total Equity 20415 18998 16949 16778 15411
Common Stock 563 558 557 557 556
Retained Earnings (Accumulated Deficit) 19445 18886 17527 16411 15185
Other Equity, Total 407 -446 -1135 -190 -330
Total Liabilities & Shareholders’ Equity 76400 71962 66646 67006 56703
Total Common Shares Outstanding 563.237 558.502 551.853 557.38 556.225
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 44835 19305 19102 18279 19443
Cash and Short Term Investments 1095 2471 2321 2749 2128
Cash & Equivalents 1095 2471 2321 2749 2128
Total Receivables, Net 4161 7710 7869 7165 8146
Accounts Receivable - Trade, Net 4142 7625 7770 7008 7977
Total Inventory 2663 5018 4947 4833 4999
Other Current Assets, Total 36916 4106 3965 3532 4170
Total Assets 75328 76413 76553 76400 80328
Property/Plant/Equipment, Total - Net 10865 18535 18576 18841 19627
Goodwill, Net 15723 30993 31045 31490 33265
Intangibles, Net 2665 4172 4249 4338 4584
Other Long Term Assets, Total 1240 3408 3581 3452 3409
Total Current Liabilities 29189 16057 15919 13658 14862
Accounts Payable 1214 1925 1998 2070 1926
Notes Payable/Short Term Debt 184 1142 1188 856 1608
Current Port. of LT Debt/Capital Leases 2162 3878 3873 2180 1758
Other Current Liabilities, Total 25629 9112 8860 8552 9570
Total Liabilities 55294 56327 56021 55985 58946
Total Long Term Debt 12770 23163 22704 24727 25241
Long Term Debt 10897 17597 17088 18986 19111
Capital Lease Obligations 1873 5566 5616 5741 6130
Deferred Income Tax 720 1640 1695 1654 1884
Minority Interest 10248 11344 11641 11803 12774
Other Liabilities, Total 2367 4123 4062 4143 4185
Total Equity 20034 20086 20532 20415 21382
Common Stock 563 563 563 563 563
Retained Earnings (Accumulated Deficit) 19041 19413 19823 19445 19156
Other Equity, Total 430 110 146 407 1663
Total Liabilities & Shareholders’ Equity 75328 76413 76553 76400 80328
Total Common Shares Outstanding 563.237 563.237 563.237 563.237 563.237
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 2117 2819 2823 3029 3714
Cash From Operating Activities 4198 5078 6549 4263 3742
Cash From Operating Activities 2973 2667 2715 2085 1133
Amortization 327 362
Deferred Taxes -115 84 43 71 100
Non-Cash Items -116 42 -60 -67 -876
Cash Taxes Paid 850 750 765 773 918
Cash Interest Paid 610 517 627 733 519
Changes in Working Capital -661 -534 1028 -1182 -691
Cash From Investing Activities -2607 -2817 -3011 -4856 -1464
Capital Expenditures -1917 -2047 -2406 -2459 -2149
Other Investing Cash Flow Items, Total -690 -770 -605 -2397 685
Cash From Financing Activities -1604 -1452 -3117 -484 -1273
Financing Cash Flow Items 45 -601 -980 381 -290
Total Cash Dividends Paid -890 -491 -468 -952 -904
Issuance (Retirement) of Stock, Net 20 38 -348 -551 55
Issuance (Retirement) of Debt, Net -779 -398 -1321 638 -134
Foreign Exchange Effects -2 118 -238 22 68
Net Change in Cash -15 927 183 -1055 1073
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 463 2117 1714 1163 599
Cash From Operating Activities 175 4198 2374 1118 101
Cash From Operating Activities 704 2973 2147 1376 693
Deferred Taxes -28 -115 -105 -89 -22
Non-Cash Items -33 -116 -69 81 -11
Cash Taxes Paid 55 850 577 430 87
Cash Interest Paid 192 610 423 271 158
Changes in Working Capital -931 -661 -1313 -1413 -1158
Cash From Investing Activities -403 -2607 -1963 -1155 -448
Capital Expenditures -358 -1917 -1187 -801 -362
Other Investing Cash Flow Items, Total -45 -690 -776 -354 -86
Cash From Financing Activities -156 -1604 -1167 -668 -375
Financing Cash Flow Items 148 45 -4 -219 470
Total Cash Dividends Paid 0 -890 -817 -367 0
Issuance (Retirement) of Stock, Net 0 20 20 20 1
Issuance (Retirement) of Debt, Net -304 -779 -366 -102 -846
Foreign Exchange Effects -44 -2 120 70 35
Net Change in Cash -428 -15 -636 -635 -687

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Fresenius SE & Co Company profile

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Fresenius SE & Co KGaA revenues increased 3% to EUR37.52B. Net income increased 7% to EUR1.82B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from EUR3.06 to EUR3.26.

Equity composition

11/2005, Rights Issue, 2 new shares for every 9 shares held @ EUR 93 (Factor: 1.025064). 02/2007, Complex capital change (Factor: 3). 07/2007, Company name changed from Fresenius AG. 8/2014, Scrip Issue, 2 new share for every 1 share held (Factor: 3).

Industry: Hospitals, Clinics & Primary Care Services

Else-Kroener Strasse 1
BAD HOMBURG
HESSEN 61352
DE

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

Gold

2,392.09 Price
+0.540% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.40

XRP/USD

0.54 Price
+0.170% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,174.45 Price
+0.250% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

65,028.15 Price
+0.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading